Fact or Fiction? Test Your Readiness to Provide Nursing Care for Youth with Seizure Clusters Outside of the Hospital

Released On
July 15, 2021

Expires On
July 15, 2022

Media Type
Internet

Completion Time
60 minutes

Specialty
Neurology, Pediatrics, Primary Care

Topic(s)
Epilepsy, Pediatrics

Scroll to the Bottom of this Information to Begin this Course

This activity is jointly provided by Medical Education Resources and CMEology.

This activity is supported by an independent educational grant from Neurelis, Inc.

Credit Available

  • Nurses — 1.0 Contact Hour

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed to meet the educational needs of nurses, including school nurses, who are involved in the care of children and adolescents.

Program Overview

Epilepsy is one of the most common chronic diseases among children and adolescents, and seizures are a frequent school health emergency. Effective rescue therapies are now available for use outside of the hospital setting to treat seizure clusters, which can progress into a seizure emergency. Nurses play a critical role in caring for youth with epilepsy, but they may find it challenging to identify and manage seizures and provide education for patients, caregivers, and coworkers that will increase their level of preparedness. In this multifaceted activity, Patricia Osborne Shafer, RN, MN, an epilepsy specialist and acclaimed educator, will discuss a practical approach to seizures and seizure clusters, seizure first aid, seizure action plans, and seizure rescue medications. The activity includes animated slides, faculty videos, and a downloadable resource handout to emphasize key clinical considerations in the care of youth with epilepsy and seizures.

Learning Goal/Purpose

The goal of this educational activity is to enhance the knowledge, competence, and confidence that nurses need to successfully provide care to youth with seizure clusters outside of the hospital setting, by enabling them to successfully employ seizure first aid, implement seizure action plans, provide FDA-approved rescue therapies, and educate patients and caregivers on these important topics.

Learning Objectives

On completion of this activity, the learner will be better able to:

  • Recognize the manifestations of seizures and seizure clusters in youth
  • Discuss the fundamental steps in the initial care of a child or adolescent who is having a seizure
  • Define the components and purpose of a well-written seizure action plan
  • Utilize FDA-approved rescue therapies with a higher level of confidence

Faculty

FACULTY_NAME

Patricia Osborne Shafer, RN, MN

Osborne Health Consulting
Epilepsy Clinical Nurse Specialist, formerly at
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Former Senior Director of Health Information
and Resources and Associate Editor of epilepsy.com, Epilepsy Foundation

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and CMEology. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

 

Nursing Credit Designation

Medical Education Resources designates this activity for a maximum of 1.0 ANCC nursing contact hour. Nurses will be awarded contact hours upon successful completion of the activity.

Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1.0 contact hour.

Disclosures of Conflicts of Interest

Medical Education Resources (MER) ensures balance, independence, objectivity, and scientific rigor in all of its educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Patricia Osborne Shafer, RN, MN

  • Consulting Fees: Neurelis, Inc.

CMEology planners have no relationships to disclose.

MER content reviewers have no relationships to disclose.

Instructions for Participation and Credit

There are no fees for participating in and receiving credit for this activity. During the period July 15, 2021 through July 15, 2022, participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest by recording the best answer to each question, and 4) complete the evaluation form.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better, with no more than 3 attempts.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of the planners. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Contact Information

For questions about this activity, please contact CMEology at: info@cmeology.org or Medical Education Resources at: http://cmepartner.org/contact.